Considering that endothelial function may be impaired by chronic hyperglycemia, acute glycemic variability, and insulin resistance through increased oxidative stress, behavior modification and pharmacotherapies aimed at reducing blood glucose levels without hypoglycemia, reducing glucose variability, and ameliorating insulin sensitivity are expected to improve endothelial function. The gene discussed is INS; the disease is Hypoglycemia.